Phoenix Molecular Designs selected to participate in Biocom’s Global Life Science Partnering Conference

Phoenix Molecular Designs was selected to participate in Biocom’s Global Life Science Partnering Conference 2017, which will be held on March 1-2, 2017.

Biocom’s Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies. The conference includes case study presentations, individual company presentations, one-one-one meetings, and numerous networking opportunities. ( )

The 10 companies best suited to pitch to prospective pharmaceutical partners will receive free admission (a $2000 USD value), as well as coaching and mentoring from an MNE experienced consultant in advance of the Conference. They are looking for drug development biotech firms that have game changing technologies targeting an unmet medical need, with secure IP, eye-popping data, and completed animal studies towards Proof-of-Concept and/or Phase 1 Human Clinical trials.

The participating companies will have the unique opportunity to engage in the San Diego BIOCOM Coaching and Mentoring Program.

The Consulate of Canada in San Diego with support from IRAP and ISED is currently recruiting companies interested in receiving coaching and mentoring in advance of the BIOCOM Global Pharma Partnering Conference which is held on March 1-2, 2017. PhoenixMD is one of the 10 companies selected in this years competition based on their competitive edge and their ability to meet the stringent requirements for the Program.

Sandi Dunn, CEO, Phoenix Molecular Designs
Cell: 778-888-0180
Office: 604-232-4600, Ext 136